| dexamethasone / Generic mfg. |
NCT00000703: Chemotherapy and Azidothymidine, With or Without Radiotherapy, for High Grade Lymphoma in AIDS-Risk Group Members |
|
|
| Completed | N/A | 45 | US | Bleomycin sulfate, Vincristine sulfate, Doxorubicin hydrochloride, Cyclophosphamide, Allopurinol, Methotrexate, Cytarabine, Leucovorin calcium, Zidovudine, Dexamethasone | National Institute of Allergy and Infectious Diseases (NIAID) | Lymphoma, Non-Hodgkin, HIV Infections | | 03/90 | | |
NCT00000723: The Use of Chemotherapy Plus Radiotherapy Plus Azidothymidine in Patients With AIDS-Related Lymph Node Cancer |
|
|
| Terminated | N/A | 45 | US | Methotrexate, Leucovorin calcium, Zidovudine, Dexamethasone | National Institute of Allergy and Infectious Diseases (NIAID) | Lymphoma, Non-Hodgkin, HIV Infections | | 03/90 | | |
ChiCTR-ONC-12002258: Effects of Gemcitabine, oxaliplatin and dexamethasone (GOD) as salvage treatment for elderly patients with refractory and relapsed peripheral T-cell lymphoma |
|
|
| Completed | N/A | 30 | | Treated with Gemcitabine, oxaliplatin and dexamethasone (GOD) regimen | Shanghai Ninth People’s Hospital Affiliated to Shanghai Jiao Tong University School of Medicine; Level of the institution：, Scientific Research Program from Health Bureau of Shanghai (grant no.2010101). | relapsed or refractory peripheral T-cell lymphoma | | | | |
NCT00317408 / 2005-003321-57: Combination Chemotherapy Followed By Stem Cell Transplant in Treating Young Patients With Progressive or Relapsed Anaplastic Large Cell Lymphoma |
|
|
| Unknown status | N/A | 96 | Europe | anti-thymocyte globulin, busulfan, carboplatin, carmustine, cyclosporine, cytarabine, dexamethasone, etoposide phosphate, idarubicin, ifosfamide, leucovorin calcium, lomustine, melphalan, methotrexate, mitoxantrone hydrochloride, prednisolone, thiotepa, vinblastine sulfate, vindesine, allogeneic hematopoietic stem cell transplantation, autologous hematopoietic stem cell transplantation, peripheral blood stem cell transplantation, total-body irradiation | European Inter-group Cooperation on Childhood and Adolescent Non Hodgkin Lymphoma | Lymphoma | 02/14 | | | |
NCT04511351: Radiotherapy Combined With GDP With or Without Chidamide in Stage I/II Extranodal Nasal NK/T-cell Lymphoma |
|
|
| Recruiting | N/A | 76 | RoW | Chidamide | Chinese Academy of Medical Sciences | Lymphoma | 12/20 | 12/20 | | |
ChiCTR2000028974: Combination of dexamethasone, pegaspargase, etoposide, gemcitabine (DPEG) in the treatment of relapsed/refractory or advanced NK/T-cell lymphoma: a prospective, single centre, single arm, phase 2 study |
|
|
| Recruiting | N/A | 29 | | DGEP therapy | Beijing Tongren Hospital; Beijing Tongren Hospital, self-sponspored | NK/T-cell lymphoma | | | | |
ChiCTR2000028715: A single arm study for doxorubicin hydrochloride liposome combined with lenalidomide, rituximab and dexamethasone in the treatment of elderly with diffuse large B-cell lymphoma |
|
|
| Not yet recruiting | N/A | 30 | | doxorubicin hydrochloride liposome combined with lenalidomide, rituximab and dexamethasone | The Second Affiliated Hospital of Army Medical University; Xinqiao Hospital, National Nature Science Fund 81370594，National Nature Science Fund 81670100 | lymphoma | | | | |
NCT05821192: Chemotherapy Plus PD-1 Monoclonal Antibody in the Treatment of Refractory or Relapsed Peripheral T-cell Lymphoma. |
|
|
| Recruiting | N/A | 34 | RoW | Rituximab, Gemcitabine, Dexamethasone, Cisplatin, PD-1 monoclonal antibody | Ou Bai, MD/PHD, Second Hospital of Jilin University, China-Japan Union Hospital, Jilin University | Peripheral T-Cell Lymphoma, Not Otherwise Specified, Angioimmunoblastic T-cell Lymphoma | 04/23 | 12/24 | | |
NCT05049785: Nutrition and Physical Activity Intervention in Preventing Excess Weight Gain in Pediatric Patients With Leukemia or Lymphoma Treated With Prednisone and/or Dexamethasone |
|
|
| Active, not recruiting | N/A | 100 | US | Counseling, Counseling Intervention, Exercise Intervention, Informational Intervention, Nutritional Intervention, Questionnaire Administration | M.D. Anderson Cancer Center, National Cancer Institute (NCI) | Leukemia, Lymphoma | 02/27 | 02/27 | | |
